Increasing Access to High-Quality Cancer Care in Rural Communities
A hub-and-spoke care delivery team is effectively bridging the gap in needs and services for patients with cancer in Montana.
Related Articles
Uncertainty reigns on Capitol Hill with government shutdown just hours away
Republicans are pursuing a Plan C they will try to pass on Friday, but it is unclear whether Democrats in the House — or the…
Giant study finds untrustworthy trials pollute gold-standard medical reviews
Nature – Two-year collaboration aims to create tools to help counter the tide of flawed research.
Home | Ask Doctor Ed
He’s called Dr. Ed — that’s Edward T. Creagan, MD, a cancer specialist, the first Mayo Clinic doctor board certified in hospice and palliative medicine.…
@elfcarescientists • Instagram photo
13 likes, 1 comments – elfcarescientists on December 18, 2024: “On the 8th day of Elfmas the Elfcare Scientists decided to stain some ‘Bone Marrow’…
“Rookie factor”: why healthcare workforce policy needs to embrace experience
What price experience? I have been working across several safety critical industries for years and in terms of the approaches that these industries take to…
An 88-Year-Old Woman Was Brought To My ER. When Her Family Told Me Why, I Was Stunned.
“I cleared my throat. ‘So, I was wondering, why did you bring Maria to the hospital today?’ Instantly all three sets of eyes filled with…
Coroner issues sternest warning to Chelsea & Westminster hospital over baby death
The coroner overseeing the inquest into the death of baby Elton Deutekom at Chelsea and Westminster hospital in January 2022 has issued a Preventing Future…
SAGE Search
Introduction The UK Government’s response to the Coronavirus pandemic was informed by its Scientific Advisory Groups for Emergencies (SAGE) ecosystem, which included the main SAGE…
The ENTIRE HEALTHCARE system is BROKEN
Vinay Prasad, MD MPH; Physician & Professor Hematologist/ OncologistProfessor of Epidemiology, Biostatistics and MedicineAuthor of 500+ Peer Reviewed papers,…
Dr Miller on the Efficacy of Selinexor in TP53 Wild-Type Endometrial Cancer
David S. Miller, MD, discusses the efficacy of selinexor in patients with advanced or recurrent TP53 wild-type endometrial cancer.
